SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012649
Filing Date
2022-08-08
Accepted
2022-08-08 16:33:10
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20220630x10q.htm   iXBRL 10-Q 1218731
2 EX-31.1 nviv-20220630xex31d1.htm EX-31.1 13863
3 EX-31.2 nviv-20220630xex31d2.htm EX-31.2 13571
4 EX-32.1 nviv-20220630xex32d1.htm EX-32.1 7516
5 EX-32.2 nviv-20220630xex32d2.htm EX-32.2 7577
  Complete submission text file 0001558370-22-012649.txt   5286423

Data Files

Seq Description Document Type Size
6 EX-101.SCH nviv-20220630.xsd EX-101.SCH 38665
7 EX-101.CAL nviv-20220630_cal.xml EX-101.CAL 39501
8 EX-101.DEF nviv-20220630_def.xml EX-101.DEF 147634
9 EX-101.LAB nviv-20220630_lab.xml EX-101.LAB 327657
10 EX-101.PRE nviv-20220630_pre.xml EX-101.PRE 260708
65 EXTRACTED XBRL INSTANCE DOCUMENT nviv-20220630x10q_htm.xml XML 907268
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 221144898
SIC: 3841 Surgical & Medical Instruments & Apparatus